Pfizer’s Covid-19 pill retains 89 percent efficacy, works on Omicron; CSL buys Vifor for US$ 11.7 billion
In
this week’s Phispers, we bring you news on several M&As and tie-ups along with updates on Covid-19 medications an...
Impressions : 1661
Drugmakers test vaccine efficacy against Omicron; FDA panel recommends Merck’s antiviral despite safety concerns
In this week’s Phispers, we bring you updates on the new Covid-19 variant – Omicron – and how vaccine makers ...
Impressions : 1870
Novartis may have a buyer for Sandoz; FDA suggests alternative approaches to assess nitrosamine risk
This week, Phispers brings you news on M&As, Covid
vaccines, lawsuits, regulations and more. Pfizer is expected to cross U...
Impressions : 2550
J&J to spin off consumer biz within two years; Biden nominates Califf as FDA chief
After a gap of a week, Phispers is back with reports of some big developments in the world of pharmaceuticals. The biggest news...
Impressions : 1857
FDA safety review to hold up Moderna’s vaccine for teens; FDA raises concerns at Biocon’s Malaysia site
This
week, Phispers has more updates from Merck. The drugmaker has temporarily
withdrawn its pre-merger notification and repo...
Impressions : 1288
Novartis may divest Sandoz unit; FDA advisors back Pfizer’s Covid jab for five to 11 year olds
This week, advisors of the US Food and Drug Administration (FDA) voted overwhelmingly in favor of recommending the Pfizer-BioNT...
Impressions : 1531
Merck’s antiviral Covid pill halves risk of hospitalization; WHO recommends malaria vaccine for Africa’s children
This week, Phispers is packed with news on M&As and deals between drugmakers. The deal of the week was Merck’s acquis...
Impressions : 2074
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.